XML 165 R31.htm IDEA: XBRL DOCUMENT
v3.24.4

Stockholders’ Equity (Deficit) (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Restructuring Cost and Reserve [Line Items] |  |
Schedule of Dividends Payable | The Company has calculated its dividends payable as follows: Schedule of Dividends Payable
|  | Series A - Convertible Preferred Stock |  |  | Series B - Convertible Preferred Stock |  |  | Total Dividends Payable |
Shares issued and outstanding |  |  | 363,000 |  |  |  | 140,000 |  |  |  |  |
Stated value per share |  | $ | 10 |  |  | $ | 10 |  |  |  |  |
Dividend rate (10%/12%) |  |  | 10 | % |  |  | 12 | % |  |  |  |
Dividend shares due per year |  |  | 363,000 |  |  |  | 168,000 |  |  |  |  |
Market price - at issuance date |  |  | 2.76 |  |  |  | 2.76 |  |  |  |  |
Minimum price - 70%/80% discount to market price |  |  | 80 | % |  |  | 70 | % |  |  |  |
Conversion price |  |  | 2.21 |  |  |  | 1.93 |  |  |  |  |
Dividend shares due per quarter |  |  | 41,101 |  |  |  | 21,739 |  |  |  |  |
Allocation for days outstanding this period end |  |  | 48.91 | % |  |  | 48.91 | % |  |  |  |
Total dividend shares due |  |  | 20,104 |  |  |  | 10,633 |  |  |  | 30,737 |
Market price - reporting period end date |  |  | 2.76 |  |  |  | 2.76 |  |  |  |  |
Fair value of dividends payable |  | $ | 55,486 |  |  | $ | 29,348 |  |  | $ | 84,834 |
Schedule of Company Nonvested Shares | A summary of the Company’s nonvested shares (due to service based restrictions) as of September 30, 2024 and December 31, 2023, is presented below: Schedule of Company Nonvested Shares
|  |  |  |  | Weighted Average |
|  | Number of |  |  | Gant Date |
Non-Vested Shares |  | Shares |  |  | Fair Value |
Balance - December 31, 2022 |  |  | 42,192 |  |  | $ | 1.40 |
Granted |  |  | 330,554 |  |  |  | 5.77 |
Vested |  |  | (104,699 | ) |  |  | 6.72 |
Cancelled/Forfeited |  |  | (153,711 | ) |  |  | 5.53 |
Balance - December 31, 2023 |  |  | 114,336 |  |  |  | 6.40 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (88,336 | ) |  |  | 5.15 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - September 30, 2024 |  |  | 26,000 |  |  | $ | 6.40 |
| A summary of the Company’s nonvested shares (due to service based restrictions) as of December 31, 2023 and 2022, is presented below: Schedule of Company Nonvested Shares
Non-Vested Shares |  | Number of Shares |  |  | Weighted Average Gant Date Fair Value |
Balance - December 31, 2021 |  |  | 15,878 |  |  | $ | 8.18 |
Granted |  |  | 48,340 |  |  |  | 12.60 |
Vested |  |  | (20,277 | ) |  |  | 53.80 |
Cancelled/Forfeited |  |  | (1,750 | ) |  |  | 40.00 |
Balance - December 31, 2022 |  |  | 42,191 |  |  |  | 1.40 |
Granted |  |  | 330,554 |  |  |  | 5.77 |
Vested |  |  | (104,698 | ) |  |  | 6.72 |
Cancelled/Forfeited |  |  | (153,711 | ) |  |  | 5.53 |
Balance - December 31, 2023 |  |  | 114,336 |  |  | $ | 5.43 |
Schedule of Stock Option Activity | Stock option transactions for the year ended December 31, 2023 is summarized as follows: Schedule of Stock Option Activity
|  |  |  |  |  |  |  | Weighted Average |  |  |  |  |  | Weighted |
|  |  |  |  | Weighted |  |  | Remaining |  |  |  |  |  | Average |
|  |  |  |  | Average |  |  | Contractual |  |  | Aggregate |  |  | Grant |
|  | Number of |  |  | Exercise |  |  | Term |  |  | Intrinsic |  |  | Date |
Stock Options |  | Options |  |  | Price |  |  | (Years) |  |  | Value |  |  | Fair Value |
Outstanding - December 31, 2022 |  |  | 37,392 |  |  | $ | 19.05 |  |  |  | 3.68 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2022 |  |  | 34,526 |  |  | $ | 19.44 |  |  |  | 3.47 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2022 |  |  | 2,866 |  |  | $ | 14.36 |  |  |  | 4.16 |  |  | $ | - |  |  | $ | - |
Granted |  |  | 101,930 |  |  | $ | 17.41 |  |  |  |  |  |  |  |  |  |  | $ | 0.73 |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (139,322 | ) |  | $ | 17.85 |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
| Stock option transactions for the years ended December 31, 2023 and 2022 are summarized as follows: Schedule of Stock Option Activity
Stock Options |  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Grant Date Fair Value |
Outstanding - December 31, 2021 |  |  | 8,769 |  |  | $ | 35.60 |  |  |  | 3.25 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2021 |  |  | 8,769 |  |  | $ | 35.60 |  |  |  | 3.25 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2021 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Granted |  |  | 28,623 |  |  | $ | 13.97 |  |  |  |  |  |  |  |  |  |  | $ | 12.49 |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2022 |  |  | 37,392 |  |  | $ | 19.05 |  |  |  | 3.68 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2022 |  |  | 34,526 |  |  | $ | 19.44 |  |  |  | 3.47 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2022 |  |  | 2,866 |  |  | $ | 14.36 |  |  |  | 4.16 |  |  | $ | - |  |  | $ | - |
Granted |  |  | 101,930 |  |  | $ | 17.41 |  |  |  |  |  |  |  |  |  |  | $ | 0.73 |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (139,322 | ) |  | $ | 17.85 |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Schedule of Fair Value Assumptions | The fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions: Schedule of Fair Value Assumptions
Expected term (years) |  |  | 5.00 |
Expected volatility |  |  | 59% - 62 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 4.00 | %
| The fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions: Schedule of Fair Value Assumptions
Expected term (years) |  |  | 5.00 |
Expected volatility |  |  | 59% - 62% |
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 4.00 | %
Expected term (years) |  |  | 5.00 |
Expected volatility |  |  | 62 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 1.64 | %
Schedule of Stock Warrant Activity | Warrant activity for the nine months ended September 30, 2024 and the year ended December 31, 2023 are summarized as follows: Schedule of Stock Warrant Activity
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  |  |  |  | Average |  |  |  |
|  |  |  |  | Weighted |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Average |  |  | Contractual |  |  | Intrinsic |
Warrants |  | Warrants |  |  | Exercise Price |  |  | Term (Years) |  |  | Value |
Outstanding - December 31, 2022 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 2.22 |  |  | $ | 82,756 |
Vested and Exercisable - December 31, 2022 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 2.22 |  |  | $ | 82,756 |
Unvested - December 31, 2022 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Vested and Exercisable - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (29,155 | ) |  | $ | 20.31 |  |  |  |  |  |  |  |  |
Outstanding - September 30, 2024 |  |  | 52,297 |  |  | $ | 4.82 |  |  |  | 0.82 |  |  | $ | 12,913 |
Vested and Exercisable - September 30, 2024 |  |  | 52,297 |  |  | $ | 4.82 |  |  |  | 0.82 |  |  | $ | 12,913 |
Unvested and non-exercisable - September 30, 2024 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
| Warrant activity for the years ended December 31, 2023 and 2022 are summarized as follows: Schedule of Stock Warrant Activity
Warrants |  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding - December 31, 2021 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 3.22 |  |  | $ | - |
Vested and Exercisable - December 31, 2021 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 3.22 |  |  | $ | - |
Unvested - December 31, 2021 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2022 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 2.22 |  |  | $ | 82,756 |
Vested and Exercisable - December 31, 2022 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 2.22 |  |  | $ | 82,756 |
Unvested - December 31, 2022 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Vested and Exercisable - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Next NRG Holding Corp [Member] |  |
Restructuring Cost and Reserve [Line Items] |  |
Schedule of Classes of Stock | The following represents the Company’s three (3) classes of stock: Schedule of Classes of Stock
September 30, 2024
|  | Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Authorized |  |  | Issued |  |  | Outstanding |  |  | Designated |  |  | Par Value |  |  | Votes Per Share |
Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Preferred Stock |  |  | 50,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 0.00001 |  |  |  |  |
Series X |  |  |  |  |  |  | 1 |  |  |  | 1 |  |  |  | 1 |  |  | $ | 0.00001 |  |  |  | A |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A |  |  | 500,000,000 |  |  |  | 17,700,000 |  |  |  | 15,000,000 |  |  |  |  |  |  | $ | 0.00001 |  |  |  | 1 |
Series B |  |  | 500,000,000 |  |  |  | 11,800,000 |  |  |  | 10,000,000 |  |  |  |  |  |  | $ | 0.00001 |  |  |  | 10 |
|  |  | 1,000,000,000 |  |  |  | 29,500,000 |  |  |  | 25,000,000 |  |  |  | - |  |  |  |  |  |  |  |  |
A - Series X will have a number of votes at any time equal to all of the number of votes held by all other voting equity securities, plus one share. Currently, the Series X preferred stockholder controls the Company through their super voting rights.
December 31, 2023
|  | Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Authorized |  |  | Issued |  |  | Outstanding |  |  | Designated |  |  | Par Value |  |  | Votes Per Share |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A |  |  | 500,000,000 |  |  |  | 17,700,000 |  |  |  | 15,000,000 |  |  |  |  |  |  | $ | 0.00001 |  |  |  | 1 |
Series B |  |  | 500,000,000 |  |  |  | 11,800,000 |  |  |  | 10,000,000 |  |  |  |  |  |  | $ | 0.00001 |  |  |  | 10 |
|  |  | 1,000,000,000 |  |  |  | 29,500,000 |  |  |  | 25,000,000 |  |  |  | - |  |  |  |  |  |  |  |  |
Schedule of Company Nonvested Series A and B of Common Stock | The following is a summary of the Company’s non-vested Series A and B shares of common stock at September 30, 2024 and December 31, 2023, respectively: Schedule of Company Nonvested Series A and B of Common Stock
|  |  |  |  | Weighted Average |
Non-Vested Shares |  | Number of Shares |  |  | Grant Date Fair Value |
Balance - December 31, 2023 |  |  | - |  |  | $ | - |
Granted |  |  | 4,500,000 |  |  |  | 2.03 |
Vested |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - September 30, 2024 |  |  | 4,500,000 |  |  | $ | 2.03 |
Unrecognized Compensation |  | $ | 8,373,750 |  |  |  |  |
Weighted average remaining period (years) |  |  | 3.67 |  |  |  |  |

X
- Definition Nonvested Restricted Stock Share Activity [Table Text Block] + References No definition available. + Details
Name: | EZFL_NonvestedRestrictedStockShareActivityTableTextBlock
Namespace Prefix: | EZFL_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringCostAndReserveLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all or some of the information related to dividends declared, but not paid, as of the financial reporting date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 + Details
Name: | us-gaap_ScheduleOfDividendsPayableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=EZFL_NextNRGHoldingCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |